Delhi HC lifts ban on another FDC used for treatment of Type II Diabetes

Delhi HC lifts ban on another FDC used for treatment of Type II Diabetes

The Delhi High Court has set aside Central Government Notification banning the manufacture, sale and distribution of drugs having Fixed Dose Combination (FDC) of ‘Pioglitazone 30 mg + Metformin 500 mg’.

Loading content, please wait...
Bar and Bench - Indian Legal news
www.barandbench.com